Shock other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
Line 10: Line 10:


{| style="border: 2px solid #A8A8A8; font-size: 70%;" align="center"
{| style="border: 2px solid #A8A8A8; font-size: 70%;" align="center"
|+ <SMALL>''Classification of shock based on hemodynamic profiles.''<ref name="isbn0-683-06754-0">{{Cite book  | last1 = Parrillo | first1 = Joseph E. | last2 = Ayres | first2 = Stephen M. | title = Major issues in critical care medicine | date = 1984 | publisher = William  Wilkins | location = Baltimore | isbn = 0-683-06754-0 | pages =  }}</ref><ref name="isbn9781405179263">{{cite book | author = Judith S. Hochman, E. Magnus Ohman | authorlink = | editor = | others = | title = Cardiogenic Shock | edition = | language = | publisher = Wiley-Blackwell | location = | year = 2009 | origyear = | pages = | quote = | isbn = 9781405179263 | oclc = | doi = | url = | accessdate = }}</ref></SMALL>
|+ <SMALL>''Classification of shock based on hemodynamic parameters.'' (CO, cardiac output; CVP; central venous pressure; PAD, pulmonary artery diastolic pressure; PAS, pulmonary artery systolic pressure; RVD, right ventricular diastolic pressure; RVS, right ventricular systolic pressure; SVO2, systemic venous oxygen saturation; SVR, systemic vascular resistance.)<ref name="isbn0-683-06754-0">{{Cite book  | last1 = Parrillo | first1 = Joseph E. | last2 = Ayres | first2 = Stephen M. | title = Major issues in critical care medicine | date = 1984 | publisher = William  Wilkins | location = Baltimore | isbn = 0-683-06754-0 | pages =  }}</ref><ref name="isbn9781405179263">{{cite book | author = Judith S. Hochman, E. Magnus Ohman | authorlink = | editor = | others = | title = Cardiogenic Shock | edition = | language = | publisher = Wiley-Blackwell | location = | year = 2009 | origyear = | pages = | quote = | isbn = 9781405179263 | oclc = | doi = | url = | accessdate = }}</ref></SMALL>
| align="center" style="background: #A8A8A8;" colspan=2 | '''Type of Shock'''
| align="center" style="background: #A8A8A8; width: 100px;"| '''Type of Shock'''
| align="center" style="background: #A8A8A8; width: 55px;"| '''CO'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''Etiology'''
| align="center" style="background: #A8A8A8; width: 55px;"| '''SVR'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''CO'''
| align="center" style="background: #A8A8A8; width: 55px;"| '''PCWP'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''SVR'''
| align="center" style="background: #A8A8A8; width: 55px;"| '''CVP'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''PCWP'''
| align="center" style="background: #A8A8A8; width: 55px;"| '''SVO2'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''CVP'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''SVO2'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''RVS'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''RVD'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''PAS'''
| align="center" style="background: #A8A8A8; width: 50px;" | '''PAD'''
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 80px;" align=center rowspan=4 | '''Cardiogenic'''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC; width: 80px;" align=center rowspan=4 | '''Cardiogenic'''
Line 24: Line 29:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑  
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑
 
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
 
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" | '''[[Mitral regurgitation|Acute Mitral Regurgitation]]'''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" | '''[[Mitral regurgitation|Acute Mitral Regurgitation]]'''
Line 32: Line 43:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" | '''[[Myocardium|Myocardial Dysfunction]]'''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" | '''[[Myocardium|Myocardial Dysfunction]]'''
Line 39: Line 57:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" | '''[[RV infarction|RV Infarction]]'''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" | '''[[RV infarction|RV Infarction]]'''
Line 46: Line 71:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓ — ↑
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" rowspan=2 align=center | '''Obstructive'''
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" rowspan=2 align=center | '''Obstructive'''
Line 54: Line 86:
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ — ↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ — ↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓ — ↑
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" |'''[[Cardiac tamponade|Cardiac Tamponade]]'''
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" |'''[[Cardiac tamponade|Cardiac Tamponade]]'''
Line 61: Line 100:
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↑
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" rowspan=2 align=center | '''Distributive'''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" rowspan=2 align=center | '''Distributive'''
Line 69: Line 115:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" | '''[[Anaphylactic shock|Anaphylactic Shock]]'''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" | '''[[Anaphylactic shock|Anaphylactic Shock]]'''
Line 76: Line 129:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↑ — ↑↑
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=center |↓
|-
|-
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" rowspan=1 align=center | '''Hypovolemic'''
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" rowspan=1 align=center | '''Hypovolemic'''
Line 83: Line 143:
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |N — ↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓
| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓


| style="font-size: 90%; padding: 0 5px; background: #F5F5F5;" align=center |↓
|}
|}



Revision as of 18:44, 17 April 2014

Shock Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Shock from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Shock other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Shock other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Shock other diagnostic studies

CDC on Shock other diagnostic studies

Shock other diagnostic studies in the news

Blogs on Shock other diagnostic studies

Directions to Hospitals Treating Shock

Risk calculators and risk factors for Shock other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Hemodynamic profile aids in classification of shock and is also valuable in directing fluid therapy in patients with cardiogenic shock.

Hemodynamic Profile

Classification of shock based on hemodynamic parameters. (CO, cardiac output; CVP; central venous pressure; PAD, pulmonary artery diastolic pressure; PAS, pulmonary artery systolic pressure; RVD, right ventricular diastolic pressure; RVS, right ventricular systolic pressure; SVO2, systemic venous oxygen saturation; SVR, systemic vascular resistance.)[1][2]
Type of Shock Etiology CO SVR PCWP CVP SVO2 RVS RVD PAS PAD
Cardiogenic Acute Ventricular Septal Defect ↓↓ N — ↑ ↑↑ ↑ — ↑↑ N — ↑ N — ↑ N — ↑
Acute Mitral Regurgitation ↓↓ ↑↑ ↑ — ↑↑ N — ↑
Myocardial Dysfunction ↓↓ ↑↑ ↑↑ N — ↑ N — ↑ N — ↑
RV Infarction ↓↓ N — ↓ ↑↑ ↓ — ↑ ↓ — ↑ ↓ — ↑
Obstructive Pulmonary Embolism ↓↓ N — ↓ ↑↑ ↓ — ↑ ↓ — ↑ ↓ — ↑
Cardiac Tamponade ↓ — ↓↓ ↑↑ ↑↑ N — ↑ N — ↑ N — ↑
Distributive Septic Shock N — ↑↑ ↓ — ↓↓ N — ↓ N — ↓ ↑ — ↑↑ N — ↓ N — ↓
Anaphylactic Shock N — ↑↑ ↓ — ↓↓ N — ↓ N — ↓ ↑ — ↑↑ N — ↓ N — ↓
Hypovolemic Volume Depletion ↓↓ ↓↓ ↓↓ N — ↓ N — ↓

References

  1. Parrillo, Joseph E.; Ayres, Stephen M. (1984). Major issues in critical care medicine. Baltimore: William Wilkins. ISBN 0-683-06754-0.
  2. Judith S. Hochman, E. Magnus Ohman (2009). Cardiogenic Shock. Wiley-Blackwell. ISBN 9781405179263.